EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity

Simei Go, Constantinos Demetriou, Giampiero Valenzano, Sophie Hughes, Simone Lanfredini, Helen Ferry, Edward Arbe-Barnes, Shivan Sivakumar, Rachel Bashford-Rogers, Mark R Middleton iD, Somnath Mukherjee, Jennifer Morton und 2 weitere

eLife · 2024

DOI: 10.7554/elife.92672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Simei Go und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Killer Cells, Natural, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Beatson Institute for Cancer Research, CRUK Scotland Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immunosuppressive microenvironment in pancreatic ductal adenocarcinoma (PDAC) prevents tumor control and strategies to restore anti-cancer immunity (i.e. by increasing CD8 T-cell activity) have had limited success. Here, we demonstrate how inducing localized physical damage using ionizing radiation (IR) unmasks the benefit of immunotherapy by increasing tissue-resident natural killer (trNK) cells that support CD8 T activity. Our data confirms that targeting mouse orthotopic PDAC tumors with IR together with CCR5 inhibition and PD1 blockade reduces E-cadherin positive tumor cells by recruiting a hypoactive NKG2D -ve NK population, phenotypically reminiscent of trNK cells, that supports CD8 T-cell involvement. We show an equivalent population in human single-cell RNA sequencing (scRNA-seq) PDAC cohorts that represents immunomodulatory trNK cells that could similarly support CD8 T-cell levels in a cDC1-dependent manner. Importantly, a trNK signature associates with survival in PDAC and other solid malignancies revealing a potential beneficial role for trNK in improving adaptive anti-tumor responses and supporting CCR5 inhibitor (CCR5i)/αPD1 and IR-induced damage as a novel therapeutic approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesKiller Cells, NaturalPancreatic NeoplasmsCarcinoma, Pancreatic DuctalAnimalsMiceHumansTumor MicroenvironmentReceptors, CCR5Mice, Inbred C57BLCell Line, TumorProgrammed Cell Death 1 ReceptorImmunotherapyNK Cell Lectin-Like Receptor Subfamily K

Stichwörter der Autor:innen

KPCNK cellscancer biologyhumanimmuneimmunologyinflammationmousepancreatictissue resident

Substanzen

Receptors, CCR5Programmed Cell Death 1 ReceptorNK Cell Lectin-Like Receptor Subfamily KCCR5 protein, mouse

Autor:innen und Institutionen

  • Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Experimental Medicine Division, University of Oxford, Oxford, United Kingdom.
  • University of Oxford Medical School, Oxford, United Kingdom.
  • Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
  • Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • CRUK Beatson Institute, Glasgow, United Kingdom.

ORCID-Profile: Mark R Middleton, Eric O Neill

Förderung

  • Cancer Research UK
  • Beatson Institute for Cancer Research
  • CRUK Scotland Centre
  • Kidani Memorial Trust
  • NIHR Oxford Biomedical Research Centre
  • Pancreatic Cancer UK

Zitieren

APA

Go, S., Demetriou, C., Valenzano, G., Hughes, S., Lanfredini, S., Ferry, H., Arbe-Barnes, E., Sivakumar, S., Bashford-Rogers, R., Middleton, M. R., Mukherjee, S., Morton, J., Jones, K., & Neill, E. O. (2024). Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity. eLife. https://doi.org/10.7554/elife.92672

Vancouver

Go S, Demetriou C, Valenzano G, Hughes S, Lanfredini S, Ferry H, et al. Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity. eLife. 2024. doi:10.7554/elife.92672

BibTeX
@article{Go2024,
  author = {Go, Simei and Demetriou, Constantinos and Valenzano, Giampiero and Hughes, Sophie and Lanfredini, Simone and Ferry, Helen and Arbe-Barnes, Edward and Sivakumar, Shivan and Bashford-Rogers, Rachel and Middleton, Mark R and Mukherjee, Somnath and Morton, Jennifer and Jones, Keaton and Neill, Eric O},
  title = {Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity},
  journal = {eLife},
  year = {2024},
  doi = {10.7554/elife.92672}
}
Kostenlos starten →